智通财经APP讯,精优药业(00858)公布截至2024年9月30日止6个月中期业绩,收益3079.2万港元,同比增长2.16%;公司拥有人应占溢利约1.01亿港元,同比扭亏为盈;基本每股盈利4.22港仙。
公告称,转亏为盈主要由于按公平值计入损益的金融资产( 即集团可换股债券投资 )的公平值变动产生收益相关非现金项目约1.112亿港元,而2023年中期期间则就同一项目的公平值变动产生亏损约2.26亿港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.